Liang et al. reported that there was decreased trend in counts of NK cells, CD4+ T cells and CD4+/CD8+ ratio with advanced NSCLC (including stage III, IV and controls groups), and no relationship between CD8+ T cells and stage [14]. The gene discussed is CD4; the disease is non-small cell lung carcinoma.